newsfilter
← Latest News
Business Wire·

Aptinyx Reports Fourth Quarter and Full Year 2021 Results and Highlights

Data readouts from Phase 2b studies of NYX-2925 in painful DPN and fibromyalgia expected in April 2022 and early to mid 3Q 2022, respectively Ongoing Phase 2 study in cognitive impairment expected to read out in late 2022 or 1Q 2023 Initiated Phas